Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s00774-017-0861-4
Published Online: 2017-08-01
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ebina, Kosuke
Hirao, Makoto
Hashimoto, Jun
Hagihara, Keisuke
Kashii, Masafumi
Kitaguchi, Kazuma
Matsuoka, Hozo
Iwahashi, Toru
Chijimatsu, Ryota
Yoshikawa, Hideki
License valid from 2017-08-01